BPC 157 has shown significant promise in treating various conditions, including neurological recovery and wound healing, due to its robust cytoprotective properties
Thus, the clinically therapeutic strategy for T2DM should not only effectively control the patients glucose levels, but also minimize the complications of bone metabolism diseases
They are not intended to diagnose, treat, cure, or prevent disease and should not replace primary care, urgent care, emergency care, or lab-guided medical evaluation when needed
Dosage for Skin Brightening For visible skin brightening and pigmentation reduction, 500 mg per day is the clinically studied dose
Kimura, I., Ozawa, K., Inoue, D., et al